If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
20.95    0.50 (2.44%)
Bid:
20.40
Ask:
21.50
Spread: 1.10 (5.392%)
Market Cap: £54.45m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

Total Voting Rights

5 Jun 2023 12:28

RNS Number : 6745B
Panthera Resources PLC
05 June 2023
 

5 June 2023

 

Panthera Resources Plc

("Panthera" or "the Company")

 

Total Voting Rights and Equity Issue Update

 

Gold exploration and development company Panthera Resources Plc (AIM: PAT), with assets in West Africa and India announces that the Company's issued share capital as at the date of this announcement comprises 152,579,671 ordinary shares of 1 pence each ("Ordinary Shares") with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 152,579,671.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Equity Issue Update

 

The Company originally announced an equity financing on 29 March 2023 and most recently provided a further update on 2 May 2023 in relation to splitting Admission into two tranches. While First Admission has since been completed, the Company now anticipates the Second Admission to occur on or around late June 2023. Further announcements regarding the equity financing will be made by the Company as and when appropriate.

 

Unless otherwise defined herein, the capitalised defined terms used in this announcement have the same meaning as those used in the Company's announcement on 2 May 2023.

 

 

 

Contacts

 

Panthera Resources PLC

Mark Bolton (Managing Director) +61 411 220 942

contact@pantheraresources.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

John Depasquale / Vivek Bhardwaj (Corporate Finance)

Kelly Gardiner / Stefano Aquilino (Sales & Corporate Broking)

 

Novum Securities Limited (Joint Broker) +44 (0) 20 7399 9400

Colin Rowbury

 

Subscribe for Regular Updates

 

Follow the Company on Twitter at @PantheraPLC

 

For more information and to subscribe to updates visit: pantheraresources.com

 

 

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRZZGGVMKKGFZM
Date   Source Headline
25th Aug 20237:00 amRNSFunding Confirmation Notice: US$13.6 million
22nd Aug 20237:13 amRNSArbitration Financing Update
21st Aug 202310:46 amRNSCompletion of Drilling at Kalaka
14th Aug 20237:00 amRNSArbitration Financing Update
31st Jul 20235:00 pmRNSTotal Voting Rights
31st Jul 20238:43 amRNSArbitration Financing Update
17th Jul 20238:07 amRNSArbitration Financing Update
11th Jul 20238:00 amRNSExecutive Service Agreement Variation
10th Jul 20237:00 amRNSKalaka Drilling Programme
4th Jul 20237:00 amRNSEquity Financing Update
3rd Jul 20237:00 amRNSArbitration Financing Update
28th Jun 202311:30 amRNSResult of Meeting
12th Jun 20237:00 amRNSNotice of GM
5th Jun 202312:28 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSArbitration Financing Update
25th May 20237:32 amRNSCascades Drilling Results
2nd May 20237:10 amRNSEquity Financing Update
2nd May 20237:00 amRNSOperations Update
19th Apr 20231:32 pmRNSEquity Issue Update
12th Apr 202310:13 amRNSDirector/PDMR Shareholding
29th Mar 20237:30 amRNSIssue of Equity
8th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
3rd Mar 20234:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSArbitration Funding for up to US$10.5 million
13th Feb 20237:00 amRNS10000m Drilling Programme Commenced at Cascades
23rd Dec 20229:14 amRNSHalf Year Report 30 September 2022
23rd Nov 202211:36 amRNSResult of AGM
12th Oct 20227:00 amRNSBido Exploration Update
10th Oct 20221:32 pmRNSEquity Financing Update
5th Oct 202212:17 pmRNSTotal Voting Rights
3rd Oct 20221:27 pmRNSEquity Financing
30th Sep 20222:08 pmRNSAnnual Financial Report 31 March 2022
7th Sep 20227:04 amRNSSignificant New Gold Discovery at Labola
5th Sep 20227:22 amRNSBassala Drilling Identifies Five Prospects
15th Aug 20227:00 amRNSWA Exploration Update
8th Jul 20227:00 amRNSCompletion of Drilling at Bassala
4th Jul 20222:13 pmRNSExercise of Options
4th Jul 20229:29 amRNSIP Survey at Bido Project
30th Jun 20227:18 amRNSCompletion of Moydow Restructure
10th Jun 20223:32 pmRNSExercise of Options and Issue of Equity
6th Jun 20227:00 amRNSDrilling Commences at Bassala
31st May 20229:09 amRNSCorporate Presentation
26th May 20221:33 pmRNSDrilling Commences at Labola
11th May 20223:47 pmRNSTR-1 Major Shareholder Notification
10th May 20221:28 pmRNSTR-1 Major Shareholder Notification
10th May 20221:18 pmRNSChange of Adviser
12th Apr 20227:00 amRNSInvestors Support Bassala Drilling Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.